Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis - Wikidata - awgldk - TriplyDB

Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis

Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q28362291

about

Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Prognostic factors associated with hepatitis C disease: a case-control study utilizing U.S. multiple-cause-of-death data Adverse reactions to first-line antituberculosis drugs.Tuberculosis and illicit drug use: review and update.Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients--a retrospective cohort study.Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus.The rational use of potentially hepatotoxic medications in patients with underlying liver disease.Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.Co-infection of hepatitis B virus and hepatitis C virus with human immunodeficiency virus infection: A cross-sectional study Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.A guide to the management of tuberculosis in patients with chronic liver disease.Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro.Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers?Isoniazid hepatotoxicity among drug users: the role of hepatitis C.BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.

P2860

Q30751889-A57C5571-69A1-4972-8EF4-3A7DC4D36516 Q33568912-18798604-678F-423F-832D-C752323D0306 Q34497890-51F90010-9584-44B9-AC27-72690D63DE70 Q34601143-357BC755-49B3-402D-A808-F45ABB2765D8 Q34603793-821CCB7B-CF69-47BD-BB9F-8F729CD75029 Q35010245-E13A703F-F530-47B0-9876-938FD505CC66 Q35194515-03602BFD-1BCA-4F41-AEAF-652DFD64B40B Q35779318-4A7C17DA-F93C-4BAE-8F17-1D0B688302C1 Q36019231-E5721C62-926A-4197-A5AA-509ACEF9350E Q36872564-F9C8CD44-801B-4D49-BA49-CFC76142456A Q37114268-C3B97529-AB95-4A56-80B1-3010662DD52D Q37366991-5ED71346-9B15-428E-A21A-6A44DA35EE5C Q37613934-11237ECE-76A6-486D-93E2-81316D38711E Q42625458-1F05F253-1E9E-4571-A18E-C99B08C305F8 Q43996273-4981B838-E603-4795-BB7C-A354A9E138B6 Q44285695-DAAF164E-D944-4E38-8103-D2BEBB0516D0 Q53851250-A3CD415E-C6CD-47D4-BBBD-D209C958650A

P2860

Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q28362291

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@ast

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@en

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@nl

type

label

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@ast

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@en

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@nl

prefLabel

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@ast

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@en

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@nl

P1433

Q28362291-145916A4-B45B-4DA4-9106-ECF83A7FB29C

P1476

Q28362291-54FD931D-AC0F-45AB-965B-09449AE9E30D

P2093

Q28362291-0B52293E-B9EC-4FF7-B93D-88648448CAD8

Q28362291-19D3BC66-0DD8-4BB1-A977-42244863EBE9

Q28362291-2B1553A5-30BB-4FC8-A7A3-D4B10CC54240

Q28362291-2E614E22-FF0D-4EF0-AEC9-ABD03075AE4D

Q28362291-35FEC3E7-D795-413A-BDD5-39486EB80B30

Q28362291-5FB12A91-F8C8-4DA8-A23E-4D434FAA375A

Q28362291-B4AB9178-DDDE-4728-ADA7-E750A458172A

Q28362291-E3D28C4E-1B90-4A67-ACD6-1322DE3A1769

P2860

Q28362291-027BBA72-AEBC-4054-BD1A-3735EF912279

Q28362291-0A00FC0B-FBE6-4CA3-A4DC-D3160D420756

Q28362291-10B4629E-9772-4733-8447-7547FFEF7936

Q28362291-1230F878-C786-42F6-915B-709EEA66C213

Q28362291-25881B05-1E33-407B-8B68-E1F9ECD6F39E

Q28362291-40232FE3-2247-4156-9F0D-43D10249E976

Q28362291-558651A3-7925-4985-91DF-5C53CED6D9FE

Q28362291-642DC3B5-C8F3-47AB-9D96-541A3D028908

Q28362291-66B34096-24F9-437D-A7CF-9699D8AE17B4

Q28362291-74F9A1FB-25E0-429A-A8A4-F423D4274C43

P304

Q28362291-99B33ED4-BD18-4455-946D-75B9248E7138

P31

Q28362291-DCC6EE79-0E10-4C25-A9FF-ED9FE803B9C7

P3181

Q28362291-1978567E-CA93-4833-9E5C-10C0D33C98F9

P356

Q28362291-89DA50CE-4F67-4DA9-91D2-B7F1DFE163DC

P407

Q28362291-9A036594-6643-4636-A3A2-F4DD2DEA63D9

P433

Q28362291-29FE3F5D-2703-4B62-BD6E-C05B4625C1DF

P478

Q28362291-F354BE4C-F1B5-4A90-BE18-0037E5F4A310

P50

Q28362291-FB544AB6-0091-43A2-ACA9-FD5121564EBC

P577

Q28362291-C2B8E6EE-1A30-4B45-B358-C6D91A651745

P5875

Q28362291-3D925398-1090-4859-AA08-9D5FAB64449E

P698

Q28362291-62B9877E-F379-4E9E-A75E-6BE6E3016CE7

P921

Q28362291-064376EA-F6D9-4C2F-89DE-1F5EF1CD3C79

Q28362291-3E7F9EA8-6109-4C64-896C-0F98D33AB1ED

Q28362291-D79411AD-8514-4BE9-876B-FB19A94DCA90

P932

Q28362291-0DBEC78F-4628-4F71-ADE9-2C3C2298A499

P3181

P356

P1433

Clinical Infectious Diseases

P1476

Isoniazid preventive therapy, ...... ith Mycobacterium tuberculosis

@en

P2093

A Madison

http://www.w3.org/2001/XMLSchema#string

D L Thomas

http://www.w3.org/2001/XMLSchema#string

D Vlahov

http://www.w3.org/2001/XMLSchema#string

J Astemborski

http://www.w3.org/2001/XMLSchema#string

L Sheely

http://www.w3.org/2001/XMLSchema#string

M Bonds

http://www.w3.org/2001/XMLSchema#string

N M Graham

http://www.w3.org/2001/XMLSchema#string

T R Sterling

http://www.w3.org/2001/XMLSchema#string

P2860

Isoniazid hepatitis in adolescents

Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study

Isoniazid-associated hepatitis in 114 patients

Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.

Isoniazid toxicity in health care workers.

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.

The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns.

Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.

P304

1687-1691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1606083

http://www.w3.org/2001/XMLSchema#string

P356

10.1086/323896

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11709399

http://www.w3.org/2001/XMLSchema#string

P698

11641824

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

infectious disease

P932

2650436

http://www.w3.org/2001/XMLSchema#string